SAS and Carolina partner to accelerate antiviral drug development

Posted Nov 19, 2021
SAS, a leader in analytics and software services, and the University of North Carolina are teaming up to transform the drug development process to prevent infectious disease threats from turning into a pandemic like COVID-19. The partnership is focused on the work of the University’s Rapidly Emerging Antiviral Drug Development Initiative (READDI). (UNC.edu)

Related: Campus Connections

Local businesses prepare to welcome Banana Ball fans
The Savannah Bananas are set to take over Kenan Stadium, bringing a sold-out event they describe as “the greatest show in sports.” The Bananas face...
Fri Apr 10, 2026

UNC alum works behind the scenes for Savannah Bananas baseball team
A mix of skills Kelly Yang learned at UNC help her play a key behind-the-scenes role for one of the most entertaining, innovative shows in...
Fri Apr 10, 2026

How UNC alum Rick Dees came to Los Angeles and became a radio legend
Born Rigdon Osmond Dees III in Jacksonville, Fla., on March 14, 1950, Rick Dees was raised in Greensboro, NC. He began his radio career while...
Thu Apr 9, 2026

Video: Carolina Insider - Interview With Former Denver Nuggets Coach and Tar Heel Dad Michael Malone
Former Denver Nuggets Head Coach, Michael Malone, also a proud UNC Volleyball parent, joins Jones Angell and Adam Lucas to talk about what it took...
Mon Apr 6, 2026